Exelixis Inc (EXEL)
21.90
-0.22
(-0.99%)
USD |
NASDAQ |
May 03, 16:00
21.90
0.00 (0.00%)
After-Hours: 20:00
Exelixis Gross Profit (Quarterly): 403.97M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 403.97M |
December 31, 2023 | 457.90M |
September 30, 2023 | 453.15M |
June 30, 2023 | 452.14M |
March 31, 2023 | 394.47M |
December 31, 2022 | 408.00M |
September 30, 2022 | 396.43M |
June 30, 2022 | 405.95M |
March 31, 2022 | 342.78M |
December 31, 2021 | 438.22M |
September 30, 2021 | 316.55M |
June 30, 2021 | 370.29M |
March 31, 2021 | 257.03M |
December 31, 2020 | 261.02M |
September 30, 2020 | 222.37M |
June 30, 2020 | 250.26M |
March 31, 2020 | 217.63M |
December 31, 2019 | 229.79M |
September 30, 2019 | 264.17M |
June 30, 2019 | 232.74M |
March 31, 2019 | 207.99M |
December 31, 2018 | 221.25M |
September 30, 2018 | 218.04M |
June 30, 2018 | 180.11M |
March 31, 2018 | 208.08M |
Date | Value |
---|---|
December 31, 2017 | 115.88M |
September 30, 2017 | 147.85M |
June 30, 2017 | 95.99M |
March 31, 2017 | 77.68M |
December 31, 2016 | 75.73M |
September 30, 2016 | 59.74M |
June 30, 2016 | 34.69M |
March 31, 2016 | 14.74M |
December 31, 2015 | 8.915M |
September 30, 2015 | 8.434M |
June 30, 2015 | 7.306M |
March 31, 2015 | 8.622M |
December 31, 2014 | 6.669M |
September 30, 2014 | 5.718M |
June 30, 2014 | 6.085M |
March 31, 2014 | 4.596M |
December 31, 2013 | 4.084M |
September 30, 2013 | 5.176M |
June 30, 2013 | 11.57M |
March 31, 2013 | 9.389M |
December 31, 2012 | 7.814M |
September 30, 2012 | 13.31M |
June 30, 2012 | 7.813M |
March 31, 2012 | 18.51M |
December 31, 2011 | 93.31M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
217.63M
Minimum
Mar 2020
457.90M
Maximum
Dec 2023
338.74M
Average
356.54M
Median
Gross Profit (Quarterly) Benchmarks
Regeneron Pharmaceuticals Inc | 2.711B |
Johnson & Johnson | 14.87B |
Merck & Co Inc | 12.24B |
Pfizer Inc | 11.50B |
Legend Biotech Corp | 47.01M |